A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
about
Biofilms: survival mechanisms of clinically relevant microorganisms.Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adultsCatheter impregnation, coating or bonding for reducing central venous catheter-related infections in adultsCentral venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapyClinical review: new technologies for prevention of intravascular catheter-related infectionsAntimicrobial-impregnated catheters for the prevention of catheter-related bloodstream infectionsPrevention of Device-Related Healthcare-Associated InfectionsUse of silver in the prevention and treatment of infections: silver review.The interaction of bacteria with engineered nanostructured polymeric materials: a reviewNew technologies to prevent intravascular catheter-related bloodstream infectionsPreventing vascular catheter-related infections: current controversies.Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens.Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome.Vascular access via peripherally inserted central venous catheters (PICCs): experience in 40 patients with acute myeloid leukemia at a single institute.Characterisation and in vitro activities of surface attached dihydropyrrol-2-ones against Gram-negative and Gram-positive bacteria.Central venous access: A new task for interventional radiologists.Can antimicrobial central venous catheters prevent associated infection?Central venous catheters: preventing infection and occlusion.The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?Toward new biomaterials.Temporary vascular access for extracorporeal therapies.Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo.Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycinPrevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.Dental biofilms: difficult therapeutic targets.Guidelines for the prevention of intravascular catheter-related infections.The impact of hospital-acquired bloodstream infections.Biofilms and device-associated infectionsEpidemiology and outcome of nosocomial and community-onset bloodstream infection.Catheter-associated infections: pathogenesis affects preventionAntimicrobial-coated/bonded and -impregnated intravascular catheters.Antibiotic resistance: prospects for the new millennium.Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review.A guide to antibiotics for the interventional radiologistThe prevention of central venous catheter-related sepsis.Susceptibility of antibiotic-resistant Gram-negative bacteria to biocides: a perspective from the study of catheter biofilms.The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections.
P2860
Q22299328-0E365E8B-24DA-45CF-A8C7-AE5BBF376326Q24186026-46B19A51-DFFF-4913-9D8B-ADF31C2FC4DAQ24202113-92435411-2965-4F57-AAF8-64CB8F9180B1Q24244252-1993B178-4E45-4402-A065-D6E6C1E88740Q24791000-B9ED005A-3CA0-45C7-81E0-6960872BD9EDQ26751587-77653DA9-42B8-4791-9737-6EBEFB48DE21Q26766147-267269B4-B7E9-441D-A69D-C832647EA547Q26779597-83894F68-C6CB-4AF7-8F87-B589641E22EDQ27024890-5D9B3A89-9630-4A88-99A6-D7CEB9B34E42Q28362185-FC3FD502-4319-47CC-99AC-0E28E3F44DF3Q30308045-F3848101-7932-4909-AFDB-DFCC3EFBC4D5Q30403958-FE9B00BB-F540-40F7-BACC-F3B7032899C1Q30424697-CEDF5859-3D8D-49A2-9EC3-800597E01997Q30482245-25EE77F5-28D8-41F8-9A10-7CDCA8586DF5Q33241226-D37064CE-DBBB-4142-9176-05DD2BDA2BD5Q33333765-E6D4FEE5-7AC8-46C2-9808-7F7166035BB0Q33337870-256066B9-9E96-43DC-9871-3DA2CDC81765Q33734723-8CEDA34C-83B0-44BB-8260-D88F94E61ADBQ33740985-8F6FD55F-B81B-46B5-ACB7-DB7967134221Q33785625-D7003463-B867-41A2-8BEE-2833A9BF27C6Q33859011-7277BD67-D672-4495-ACC4-87AF1295A88CQ33957878-86D5C4D8-865A-4DAF-9799-A073C5A1F165Q33957905-A7F9D866-ADE7-4C47-A87C-19654FF018BAQ33979770-E2007C33-9537-489C-A3AA-9478AF979D55Q33982121-3A3B18AB-57D9-4427-9528-CB1350926A3BQ33983463-C8162A89-CFB0-452D-82F9-C34CECE78F0DQ34057519-8F8190C4-6437-4637-A85C-DA68FC1E0869Q34128638-7AB7E5E7-03FB-44F4-B6DC-D33859C351C0Q34175393-EE5E143E-34A5-4A95-AE41-260EB7C6D2D1Q34213597-6FA5C1FC-CD10-4957-BC89-C2DBC60FF967Q34213700-DDD7C5C3-3D2E-43AF-8A4A-DDB621E38B8CQ34220412-311E99A8-4F4B-452C-AEE3-A6DBCBD25EA5Q34237921-A229F5B1-8185-4BEA-A447-6C25B491CA9CQ34417307-61DAA2B7-16CD-4F48-907C-5BF1494A4508Q34503819-89A12355-0CA9-4C4E-BF65-54D27DD7BD23Q34503825-1132C81E-A898-47C3-BE63-AC17248472A3Q34563237-043F01A3-3CF7-4AC0-AC0A-E59128E5F86CQ34590070-F3ABC06A-5DEF-482D-8717-F3004D46FA05Q34631490-1290961B-496E-4BC3-A6F7-7D46AC5358BEQ34667434-721BA97F-8D56-4D71-BC02-C7A8159B2AAE
P2860
A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A comparison of two antimicrob ...... theters. Catheter Study Group.
@en
A comparison of two antimicrob ...... theters. Catheter Study Group.
@nl
type
label
A comparison of two antimicrob ...... theters. Catheter Study Group.
@en
A comparison of two antimicrob ...... theters. Catheter Study Group.
@nl
prefLabel
A comparison of two antimicrob ...... theters. Catheter Study Group.
@en
A comparison of two antimicrob ...... theters. Catheter Study Group.
@nl
P2093
P1476
A comparison of two antimicrob ...... theters. Catheter Study Group.
@en
P2093
Darouiche RO
Gabrielli A
Khardori N
P356
10.1056/NEJM199901073400101
P407
P577
1999-01-01T00:00:00Z